National Asset Management, Inc. Pfizer Inc Transaction History

National Asset Management, Inc.

$3.82 Billion
Q2 2024

A detailed history of National Asset Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, National Asset Management, Inc. holds 365,151 shares of PFE stock, worth $10.6 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

365,151

Previous 327,696 11.43%

Holding current value

$10.6 Million

Previous $9.09 Million 12.35%

% of portfolio

0.27%

Previous 0.21%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 19, 2024	BUY	$25.26 - $29.6 $946,113 - $1.11 Million	37,455 Added 11.43%	365,151 $10.2 Million
Q1 2024 May 16, 2024	BUY	$25.89 - $29.73 $1.27 Million - $1.46 Million	49,129 Added 17.64%	327,696 $9.09 Million
Q4 2023 Mar 15, 2024	SELL	$26.13 - $33.94 $1.28 Million - $1.67 Million	-49,129 Reduced 14.99%	278,567 $8.02 Million
Q3 2023 Dec 01, 2023	SELL	$32.09 - $37.51 $34,593 - $40,435	-1,078 Reduced 0.33%	327,696 $10.9 Million
Q2 2023 Jul 27, 2023	SELL	$36.12 - $41.79 $716,079 - $828,486	-19,825 Reduced 5.69%	328,774 $12.1 Million
Q1 2023 May 17, 2023	BUY	$39.39 - $51.28 $92,724 - $120,713	2,354 Added 0.68%	348,599 $14.2 Million
Q4 2022 Mar 15, 2023	SELL	$41.75 - $54.5 $687,330 - $897,233	-16,463 Reduced 4.54%	346,245 $17.7 Million
Q4 2022 Feb 21, 2023	BUY	$41.75 - $54.5 $1.07 Million - $1.4 Million	25,677 Added 7.62%	362,708 $18.6 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $6.19 Million - $7.56 Million	141,534 Added 72.4%	337,031 $14.8 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $1.06 Million - $1.26 Million	-22,867 Reduced 10.47%	195,497 $10.3 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $5.98 Million - $7.42 Million	-130,802 Reduced 37.46%	218,364 $11.3 Million
Q4 2021 Jan 28, 2022	SELL	$41.32 - $61.25 $19,627 - $29,093	-475 Reduced 0.14%	349,166 $20.6 Million
Q3 2021 Nov 16, 2021	BUY	$39.25 - $50.42 $597,502 - $767,543	15,223 Added 4.55%	349,641 $15 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $3.35 Million - $3.8 Million	93,382 Added 38.74%	334,418 $13.1 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $2.6 Million - $2.93 Million	77,592 Added 47.47%	241,036 $8.74 Million
Q4 2020 Feb 04, 2021	SELL	$33.47 - $42.56 $563,467 - $716,497	-16,835 Reduced 9.34%	163,444 $6.02 Million
Q3 2020 Nov 09, 2020	BUY	$31.75 - $37.25 $1.65 Million - $1.93 Million	51,913 Added 40.44%	180,279 $6.49 Million
Q2 2020 Jul 31, 2020	BUY	$30.12 - $36.54 $47,770 - $57,952	1,586 Added 1.25%	128,366 $4.2 Million
Q1 2020 May 06, 2020	SELL	$27.03 - $38.62 $303,384 - $433,470	-11,224 Reduced 8.13%	126,780 $4.14 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $300,263 - $340,760	9,121 Added 7.08%	138,004 $5.41 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $877,392 - $1.14 Million	27,005 Added 26.51%	128,883 $4.63 Million
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $573,855 - $644,307	15,518 Added 17.97%	101,878 $4.42 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $10,687 - $11,742	-285 Reduced 0.33%	86,360 $3.67 Million
Q4 2018 Feb 08, 2019	BUY	$38.47 - $43.86 $39,893 - $45,482	1,037 Added 1.21%	86,645 $3.79 Million
Q3 2018 Nov 08, 2018	BUY	$34.47 - $41.81 $193,893 - $235,181	5,625 Added 7.03%	85,608 $3.78 Million
Q2 2018 Oct 05, 2018	BUY	$32.98 - $35.16 $71,797 - $76,543	2,177 Added 2.8%	79,983 $2.9 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $1.01 Million - $1.17 Million	-31,674 Reduced 28.93%	77,806 $2.76 Million
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $7,184 - $7,622	216 Added 0.2%	109,480 $3.97 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $34,844 - $38,384	1,124 Added 1.04%	109,264 $3.9 Million
Q2 2017 Aug 15, 2017	BUY	N/A	108,140	108,140 $3.64 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.

Account

National Asset Management, Inc. Pfizer Inc Transaction History